DV
Dr Vishal Sikka BOARD MEMBER
Insider track record Other Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Dr Vishal Sikka. Director active across 1 company, notably GSK plc. In total, 27 filings have been published. History available since 20 June 2023. The latest transaction was filed on 22 June 2026 (Purchase). Regulator: RNS (LSE). The full history is openly available.
Declarations 27 total
● Independent Non-Executive Director · Executives · 22 Jun 2026 · GSK plc 1,266 shares @ £50.6908 0.0001% mcap 92.1% of flow US37733W2044⌘ RNS:9632737-6 Ideal exit: 19 Mar 2027 (T+270) ● Independent Non-Executive Director · Executives · 22 Jun 2026 · GSK plc 1,266 shares @ £0.5069 0.0000% mcap 11.7% of flow US37733W2044⌘ RNS:1cabaef6-2e05-4f58-a412-24a2f7509642-6 Ideal exit: 19 Mar 2027 (T+270) ● Independent Non-Executive Director · Executives · 9 Apr 2026 · GSK plc 96 shares @ £0.5893 0.0000% mcap 1.2% of flow US37733W2044⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-16 Ideal exit: 4 Jan 2027 (T+270) ● Independent Non-Executive Director · Executives · 20 Mar 2026 · GSK plc 797 shares @ £0.5179 0.0000% mcap 8.7% of flow US37733W2044⌘ RNS:c2055913-103f-4927-b6f8-8f0835af9e8e-8 Ideal exit: 15 Dec 2026 (T+270) ● Independent Non-Executive Director · Executives · 9 Jan 2026 · GSK plc 94 shares @ £0.5044 1.0% of flow US37733W2044⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-40 Ideal exit: 6 Oct 2026 (T+270) ● Independent Non-Executive Director · Executives · 19 Dec 2025 · GSK plc 730 shares @ £0.4855 7.4% of flow US37733W2044⌘ RNS:5a98a0c7-d756-450b-83e9-f26937fe1a0f-6 Ideal exit: 15 Sept 2026 (T+270) ● Independent Non-Executive Director · Executives · 10 Oct 2025 · GSK plc 99 shares @ £0.4374 1.1% of flow US37733W2044⌘ RNS:5859068-31 Ideal exit: 7 Jul 2026 (T+270) ● Independent Non-Executive Director · Executives · 19 Sept 2025 · GSK plc 827 shares @ £0.4074 8.5% of flow US37733W2044⌘ RNS:5830475-7 Ideal exit: 16 Jun 2026 (T+270) ● Independent Non-Executive Director · Executives · 11 Jul 2025 · GSK plc 103 shares @ £0.3854 1.0% of flow US37733W2044⌘ RNS:5737340-38 Ideal exit: 7 Apr 2026 (T+270) ● Independent Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 889 shares @ £0.379 9.7% of flow US37733W2044⌘ RNS:5708028-8 Ideal exit: 17 Mar 2026 (T+270) ● Independent Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 889 shares @ £0.379 9.7% of flow US37733W2044⌘ RNS:5707630-8 Ideal exit: 17 Mar 2026 (T+270) ● Independent Non-Executive Director · Executives · 11 Apr 2025 · GSK plc 98 shares @ £0.3412 0.9% of flow US37733W2044⌘ RNS:5617047-7 Ideal exit: 6 Jan 2026 (T+270) ● Independent Non-Executive Director · Executives · 20 Mar 2025 · GSK plc 857 shares @ £0.3927 12.3% of flow US37733W2044⌘ RNS:5584787-9 Ideal exit: 15 Dec 2025 (T+270) ● Independent Non-Executive Director · Executives · 10 Jan 2025 · GSK plc 80 shares @ £0.3335 1.0% of flow US37733W2044⌘ RNS:5498728-23 Ideal exit: 7 Oct 2025 (T+270) ● Independent Non-Executive Director · Executives · 20 Dec 2024 · GSK plc 937 shares @ £0.3381 11.8% of flow US37733W2044⌘ RNS:5479029-9 Ideal exit: 16 Sept 2025 (T+270) ● Independent Non-Executive Director · Executives · 11 Oct 2024 · GSK plc 64 shares @ £0.3906 1.2% of flow US37733W2044⌘ RNS:5388451-7 Ideal exit: 8 Jul 2025 (T+270) ● Independent Non-Executive Director · Executives · 23 Sept 2024 · GSK plc 773 shares @ £0.4101 15.6% of flow US37733W2044⌘ RNS:5362280-8 Ideal exit: 20 Jun 2025 (T+270) ● Independent Non-Executive Director · Executives · 12 Jul 2024 · GSK plc 51 shares @ £0.3933 1.2% of flow US37733W2044⌘ RNS:5266837-16 Ideal exit: 8 Apr 2025 (T+270) ● Independent Non-Executive Director · Executives · 20 Jun 2024 · GSK plc 1,179 shares @ £0.4077 28.1% of flow US37733W2044⌘ RNS:5235239-8 Ideal exit: 17 Mar 2025 (T+270) ● Independent Non-Executive Director · Executives · 12 Apr 2024 · GSK plc 43 shares @ £0.4095 1.0% of flow US37733W2044⌘ RNS:5143847-30 Ideal exit: 7 Jan 2025 (T+270) ● Independent Non-Executive Director · Executives · 20 Mar 2024 · GSK plc 756 shares @ £0.419 26.3% of flow US37733W2044⌘ RNS:5116598-9 Ideal exit: 15 Dec 2024 (T+270) ● Independent Non-Executive Director · Executives · 12 Jan 2024 · GSK plc 32 shares @ £0.4009 1.1% of flow US37733W2044⌘ RNS:5034561-29 Ideal exit: 8 Oct 2024 (T+270) ● Independent Non-Executive Director · Executives · 20 Dec 2023 · GSK plc 727 shares @ £0.3661 30.1% of flow US37733W2044⌘ RNS:5012405-9 Ideal exit: 15 Sept 2024 (T+270) ● Independent Non-Executive Director · Executives · 13 Oct 2023 · GSK plc 26 shares @ £0.3688 1.1% of flow US37733W2044⌘ RNS:4939502-8 Ideal exit: 9 Jul 2024 (T+270) ● Independent Non-Executive Director · Executives · 20 Sept 2023 · GSK plc 790 shares @ £0.3803 33.9% of flow US37733W2044⌘ RNS:4907954-8 Ideal exit: 16 Jun 2024 (T+270) 25 of 27 declarations
Load more (2 remaining) About Dr Vishal Sikka Dr Vishal Sikka has made 27 filings, all related to GSK plc, where he is an Independent Non-Executive Director. Between June 23, 2023, and June 24, 2026, he executed purchases totaling 80245 euros, with notable transactions including a purchase of 73941.92 euros on June 24, 2026, and another of 739.42 euros on June 23, 2026.